Shares Offered at $3.25 Each
On April 21, 2026, SBC Medical Group Holdings Incorporated plans to close its secondary public offering of 3.1 million shares of common stock, priced at $3.25 each. This announcement was made following the company’s registration statement filed with the U.S. Securities and Exchange Commission (SEC). Dr. Yoshiyuki Aikawa, the selling stockholder, is responsible for selling these shares, and SBC Medical will not gain any proceeds from this sale. underwriters have a 45-day option to purchase up to 465,000 more shares.
Maxim Group LLC is managing the offering as the sole book-running manager, with Roth Capital Partners as the co-manager. Investors are advised to read the preliminary prospectus supplement and accompanying prospectus filed with the SEC for detailed information about the offering. These documents are available for free on the SEC’s website or by contacting Maxim Group LLC directly, ensuring transparency and informed decision-making.
SBC Medical Group Holdings, a Management Service Organisation, operates a diverse array of franchise businesses across medical fields such as dermatology, orthopedics, and fertility treatment. Since its Nasdaq listing in September 2024, SBC Medical has expanded its presence in the U.S. and Asia. The company was included in the Russell 3000 Index in June 2025, reflecting its growing influence in the U.S. equity market.
The offering is being conducted under SBC Medical’s effective shelf registration statement on Form S-3. This initiative underscores the company’s commitment to providing high-quality medical services while expanding internationally.
SBC Medical continues to innovate in fields like advanced aesthetic healthcare, dentistry, and alopecia treatment. The company’s strategic positioning in Asia is aimed at capturing growth opportunities in the rapidly expanding healthcare sector.
This announcement is not an offer to sell or a solicitation of an offer to buy these securities in any jurisdiction where such an offer or sale would be illegal before registration or qualification under the securities laws.
